VRTX — Vertex Pharmaceuticals Incorporated | Setup 8-12 Jun 2026
VRTX
Vertex Pharmaceuticals Incorporated
SCORE IQS Lite
60/100
Structure 1W 17
Momentum 1D 25
Ichimoku 1W 15
CMF 1D 0
Delta 3
IQS Lite Components · What they measure
IQS Lite Components · What they measure
Structure 1W — MA alignment and solidity of the underlying trend
Momentum 1D — Directional strength and momentum acceleration
Ichimoku 1W — Price position relative to the Kumo cloud
CMF 1D — Capital pressure: inflows or outflows
Delta — IQS score change vs previous week (W-1)
Each axis ranges 0-20 pt · sum = total IQS Lite (0-100)
Executive View
Daily momentum remains strong with MACD in bullish territory, though weekly MACD signals fading pressure. Price consolidates within the tight compression zone. The setup privileges entry confirmation on breakout above 451.42 or breakdown below 434.01, with risk management essential given the stretched phase of the cycle.
📅 Earnings: 2026-07-30
Chart · 12-month trend
Charts provided by TradingView